CCG
CVS icon

Cypress Capital Group’s CVS Health CVS Stock Holding History

Cypress Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,654
Closed -$418K – 266
2024
Q3 		$418K Buy
6,654
+320
+5% +$18.7K 0.05% 239
2024
Q2 		$374K Sell
6,334
-3,467
-35% -$217K 0.04% 232
2024
Q1 		$782K Buy
9,801
+44
+0.5% +$3.36K 0.09% 176
2023
Q4 		$770K Sell
9,757
-1,012
-9% -$72K 0.1% 171
2023
Q3 		$752K Sell
10,769
-9,458
-47% -$670K 0.11% 166
2023
Q2 		$1.4M Sell
20,227
-1,163
-5% -$82.8K 0.2% 107
2023
Q1 		$1.59M Sell
21,390
-709
-3% -$59.5K 0.24% 88
2022
Q4 		$2.06M Sell
22,099
-1,406
-6% -$136K 0.31% 76
2022
Q3 		$2.24M Buy
23,505
+1,978
+9% +$196K 0.37% 70
2022
Q2 		$2M Sell
21,527
-759
-3% -$74.1K 0.3% 84
2022
Q1 		$2.26M Buy
22,286
+303
+1% +$31.8K 0.28% 92
2021
Q4 		$2.27M Buy
21,983
+1,247
+6% +$115K 0.28% 92
2021
Q3 		$1.76M Sell
20,736
-73
-0.4% -$6.12K 0.24% 97
2021
Q2 		$1.74M Buy
20,809
+2,141
+11% +$175K 0.24% 100
2021
Q1 		$1.4M Buy
18,668
+4,155
+29% +$303K 0.2% 109
2020
Q4 		$991K Buy
14,513
+108
+0.7% +$7.03K 0.15% 122
2020
Q3 		$841K Buy
14,405
+3,693
+34% +$230K 0.14% 134
2020
Q2 		$696K Buy
10,712
+3,363
+46% +$212K 0.13% 136
2020
Q1 		$436K Sell
7,349
-1,973
-21% -$132K 0.1% 132
2019
Q4 		$693K Buy
9,322
+400
+4% +$28.1K 0.12% 135
2019
Q3 		$562K Sell
8,922
-1,878
-17% -$111K 0.11% 149
2019
Q2 		$589K Sell
10,800
-788
-7% -$42.4K 0.12% 139
2019
Q1 		$625K Sell
11,588
-956
-8% -$59K 0.13% 134
2018
Q4 		$822K Sell
12,544
-3,509
-22% -$262K 0.19% 108
2018
Q3 		$1.26M Sell
16,053
-100
-0.6% -$7.15K 0.24% 101
2018
Q2 		$1.04M Sell
16,153
-1,483
-8% -$97.7K 0.21% 108
2018
Q1 		$1.1M Sell
17,636
-12
-0.1% -$861 0.23% 102
2017
Q4 		$1.28M Sell
17,648
-270
-2% -$19.6K 0.27% 94
2017
Q3 		$1.46M Sell
17,918
-6,860
-28% -$543K 0.31% 88
2017
Q2 		$1.99M Sell
24,778
-8,949
-27% -$707K 0.44% 74
2017
Q1 		$2.65M Buy
33,727
+22,180
+192% +$1.77M 0.62% 59
2016
Q4 		$911K Buy
11,547
+5,042
+78% +$408K 0.22% 94
2016
Q3 		$579K Buy
6,505
+1,845
+40% +$174K 0.14% 118
2016
Q2 		$446K Sell
4,660
-1,512
-24% -$151K 0.1% 128
2016
Q1 		$640K Buy
6,172
+1,427
+30% +$139K 0.16% 106
2015
Q4 		$464K Sell
4,745
-1,416
-23% -$139K 0.11% 128
2015
Q3 		$595K Sell
6,161
-110
-2% -$11.6K 0.15% 118
2015
Q2 		$658K Buy
6,271
+2,085
+50% +$213K 0.15% 118
2015
Q1 		$432K Sell
4,186
-498
-11% -$50.4K 0.1% 154
2014
Q4 		$451K Buy
4,684
+350
+8% +$30.8K 0.1% 142
2014
Q3 		$344K Hold
4,334
– – 0.08% 159
2014
Q2 		$327K Sell
4,334
-500
-10% -$37.8K 0.08% 167
2014
Q1 		$362K Buy
4,834
+344
+8% +$24.3K 0.09% 150
2013
Q4 		$322K Hold
4,490
– – 0.08% 152
2013
Q3 		$255K Sell
4,490
-100
-2% -$5.96K 0.06% 169
2013
Q2 		$262K Buy
+4,590
New +$266K 0.05% 179

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cypress Capital Group's CVS Position: Q4 2024 in Review

Cypress Capital Group sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,654 shares — an estimated $418K sold.

Cypress Capital Group first reported a position in CVS in Q2 2013 and held it in 46 quarters. The position peaked at $2.65M in Q1 2017. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Cypress Capital Group reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Cypress Capital Group sold 6,654 CVS Health shares in Q4 2024, an estimated $418K.
  • Cypress Capital Group first reported a position in CVS Health in Q2 2013 and held it in 46 quarters.
  • Cypress Capital Group's CVS Health position peaked at $2.65M in Q1 2017.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Cypress Capital Group's 13F filing for Q4 2024, filed 6 Feb 2025.